71 - Increasing Trends in Multimorbidity and Polypharmacy Over a 5-Year Period in People Living with HIV in the United States

On Demand

Participants should be aware of the following financial/non-financial relationships:

Misti Paudel, PhD: Merck (Other Financial or Material Support, This study was funded by Merck & Co.)

Girish Prajapati, M.B.B.S., MPH : Merck & Co., Inc. (Employee, Shareholder)

Erin K. Buysman, MS: Merck & Co., Inc. (Other Financial or Material Support, I am an employee of Optum, which was contracted by Merck to complete the research described in this abstract)

Swarnali Goswami, M.Pharm: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Jianbin Mao, PhD: Merck & Co. (Employee, Shareholder)

Kimberly McNiff, MPH: Merck (Other Financial or Material Support, Merck funded the research project)

Princy N. Kumar, MD: Amgen (Consultant)Eli Lilly (Grant/Research Support)Gilead (Consultant, Grant/Research Support, Shareholder)GSK (Consultant, Grant/Research Support, Shareholder)Merck (Consultant, Grant/Research Support, Shareholder, Honoraria)

Co-Author(s)

MP

Misti Paudel, PhD

Senior Researcher
Optum
Eden Prairie, MN, United States

Disclosure: Merck (Other Financial or Material Support, This study was funded by Merck & Co.)
GP

Girish Prajapati, M.B.B.S., MPH

Director
Merck & Co., Inc.
Rahway, New Jersey, United States

Disclosure: Merck & Co., Inc. (Employee, Shareholder)
EB

Erin K. Buysman, MS

Director
Optum
Eden Prairie, Minnesota, United States

Disclosure: Merck & Co., Inc. (Other Financial or Material Support, I am an employee of Optum, which was contracted by Merck to complete the research described in this abstract)
SG

Swarnali Goswami, M.Pharm

Merck & Co., Inc., Kenilworth, NJ (Author was working under an internship in partnership with The University of Mississippi, University, MS)
University, Mississippi, United States

Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
JM

Jianbin Mao, PhD

Director of Global Value and Access
Acceleron Pharma
Cambridge, Massachusetts, United States

Disclosure: Merck & Co. (Employee, Shareholder)
KM

Kimberly McNiff, MPH

Senior Analyst
Optum
Minneapolis, Minnesota, United States

Disclosure: Merck (Other Financial or Material Support, Merck funded the research project)

Presenting Author(s)

Princy N. Kumar, MD

Chief Division of Infectious Diseases
Georgetown University Hospital
Potomoc, MD, United States

Disclosure: Amgen (Consultant)Eli Lilly (Grant/Research Support)Gilead (Consultant, Grant/Research Support, Shareholder)GSK (Consultant, Grant/Research Support, Shareholder)Merck (Consultant, Grant/Research Support, Shareholder, Honoraria)

Slides Slides and Audio